[Specific measures in drug therapy in stroke. Anticoagulants, inhibitors of thrombocyte aggregation, initial barbiturate therapy].
D000925:Anticoagulants / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use; D001463:Barbiturates / Q000627:therapeutic use*; D002339:Carotid Arteries / Q000601:surgery; D002544:Cerebral Infarction / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D003374:Coumarins / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects*
D000925:Anticoagulants; D001463:Barbiturates; D003374:Coumarins; D006493:Heparin; D001241:Aspirin
Besondere Verfahren der Pharmakotherapie bei Schlaganfällen. Antikoagulantien, Thrombozytenaggregationshemmer, initiale Barbiturattherapie.